|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/395 | (2006.01) | ||
| A61K 31/41 | (2006.01) | ||
| A61K 31/4188 | (2006.01) | ||
| C07H 19/23 | (2006.01) | ||
| A61K 31/7052 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 2937350 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15155479.7 |
| Date of filing the European patent application | 2009-04-22 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation | 2018-04-10 |
| (30) | Number | Date | Country code |
| 47263 P | 2008-04-23 | US | |
| 139449 P | 2008-12-19 | US |
| (72) |
Butler, Thomas, US
Cho, Aesop, US
Kim, Choung, U., US
Saunders, Oliver, L., US
Zhang, Lijun, US
Parrish, Jay, US
|
| (73) |
GILEAD SCIENCES, INC.,
333 Lakeside Drive, Foster City, California 94404,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 1'-pakeistieji karba-nukleozidų analogai, skirti antivirusiniam gydymui |
| 1'-substituted carba-nucleoside analogs for antiviral treatment |
| Payment date | Validity (years) | Amount | |
| 2025-03-18 | 17 | 347.00 EUR |
| 2026-04-22 |